Skip to main content
NCBI home page
Gut logoLink to Gut
. 1981 Jul;22(7):571–574. doi: 10.1136/gut.22.7.571

Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.

C Andre, L Descos, P Landais, J Fermanian
PMCID: PMC1419331  PMID: 6973509

Abstract

The ability of 11 laboratory parameters to reflect the degree of activity of Crohn's disease, using a clinical index as reference point was compared by means of multiple stepwise regression analysis. Activity was best defined in decreasing order by orosomucoid, sedimentation rate, C reactive protein, alpha-1-antitrypsin, albumin, haematocrit, IgM, circulating immune complexes, serum iron, IgG, and IgA. The haematocrit, the only laboratory measurement in the Crohn's disease activity index developed by the National Cooperative Study Group in the USA, is less discriminant than acute phase reactants. Only three parameters-namely, orosomucoid, sedimentation rate, and C reactive protein-have a significant weight and should be complementary to a simple clinical index.

Full text

PDF
571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. André C., Descos L., André F., Vignal J., Druguet M. Intérêt du dosage de la protéine C dans le diagnostic et la mesure de l'activité de la maladie de Crohn et de la rectocolite hémorragique. Gastroenterol Clin Biol. 1979 Nov;3(11):789–794. [PubMed] [Google Scholar]
  2. André C., Descos L., Cerf M. Comment convient-il d'apprécier l'activité de la maladie de Crohn? Plaidoyer pour un index biologique et clinique. une étude coopérative du Groupe de Recherche sur les Entérocolites Cryptogénétiques (GREC). Gastroenterol Clin Biol. 1979 Nov;3(11):785–787. [PubMed] [Google Scholar]
  3. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  4. Best W. R., Becktel J. M., Singleton J. W. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology. 1979 Oct;77(4 Pt 2):843–846. [PubMed] [Google Scholar]
  5. Elliott P. R., Lennard-Jones J. E., Hathway N. Simple index of Crohn's disease activity. Lancet. 1980 Apr 19;1(8173):876–876. doi: 10.1016/s0140-6736(80)91372-0. [DOI] [PubMed] [Google Scholar]
  6. Grangeot L., Pillot J. Mise en évidence d'immuncomplexes circulants chez l'homme; précipitation des immuncomplexes par le polyéthylène glycol et leur caractérisation par le Clq lié aux immunoglobulines. C R Acad Sci Hebd Seances Acad Sci D. 1975 Mar 3;280(9):1201–1203. [PubMed] [Google Scholar]
  7. Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
  8. O'Donoghue D. P., Dawson A. M., Powell-Tuck J., Bown R. L., Lennard-Jones J. E. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet. 1978 Nov 4;2(8097):955–957. doi: 10.1016/s0140-6736(78)92524-2. [DOI] [PubMed] [Google Scholar]
  9. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Teixeira M., Ferguson A. Uses and limitations of the Crohn's disease activity index. Arq Gastroenterol. 1979 Apr-Jun;16(2):67–72. [PubMed] [Google Scholar]
  11. van Hees P. A., van Elteren P. H., van Lier H. J., van Tongeren J. H. An index of inflammatory activity in patients with Crohn's disease. Gut. 1980 Apr;21(4):279–286. doi: 10.1136/gut.21.4.279. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES